Understanding Factors Affecting University A Students' Decision to Receive an Unlicensed Serogroup B Meningococcal Vaccine

Breakwell, Lucy; Vogt, Tara M.; Fleming, Debbie; Ferris, Mary; Briere, Elizabeth; Cohn, Amanda C.; Liang, Jennifer L.

doi:10.1016/j.jadohealth.2016.06.004

Cited by 14 publications

(14 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Yet, our study contributes novel and timely evidence to understand the need for greater parental awareness MenB vaccines, a topic for which there is very limited data. Previous studies investigating the willingness to receive MenB vaccines have been undertaken only in the context of an outbreak [ 24 ] or in countries outside the US where vaccination recommendations differ significantly [ 16 – 23 ]. We have provided evidence that awareness of MenB vaccine is lacking among parents of teens in the US and that awareness of MenB vaccines, along with concern for meningococcal disease, are important predictors of willingness to vaccinate with the newly licensed MenB vaccines.…”

Section: Discussionmentioning

confidence: 99%

“…Increasing vaccine uptake and ensuring the sustainability of high uptake of both MenAWCY and MenB vaccines is critical to achieving this goal. While studies have been conducted in other countries to address knowledge and attitudes about the recently developed MenB vaccines [ 16 – 23 ], only one study has investigated awareness of MenB vaccine in the US [ 24 ]. Breakwell et al investigated uptake in the context of an ongoing MenB outbreak and found 51% MenB vaccine coverage among a college student population at a time when the vaccine was not yet licensed; vaccinees were motivated by the knowledge that meningitis is a serious disease and that vaccination is the best way to protect oneself [ 24 ].…”

Section: Introductionmentioning

confidence: 99%

“…While studies have been conducted in other countries to address knowledge and attitudes about the recently developed MenB vaccines [ 16 – 23 ], only one study has investigated awareness of MenB vaccine in the US [ 24 ]. Breakwell et al investigated uptake in the context of an ongoing MenB outbreak and found 51% MenB vaccine coverage among a college student population at a time when the vaccine was not yet licensed; vaccinees were motivated by the knowledge that meningitis is a serious disease and that vaccination is the best way to protect oneself [ 24 ]. Now that MenB vaccines are licensed in the US, recommended, and more widely available, parents of teenagers have the opportunity to have their children vaccinated with both MenB and MenACWY vaccines to protect against 5 disease-causing serogroups.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Parental awareness of Meningococcal B vaccines and willingness to vaccinate their teens

Basta

Becker

et al. 2019

Vaccine

View full text Add to dashboard Cite

Background: In the US, Meningococcal B (MenB) vaccines were first licensed in 2014. In 2015, the Advisory Committee on Immunization Practices recommended that parents of teens talk to their provider about receiving MenB vaccine, rather than issuing a routine recommendation. We assessed parental awareness of MenB vaccines and willingness to vaccinate their teens with MenB vaccines compared to MenACWY vaccines, which have been routinely recommended for many years. Methods: We surveyed parents of teens attending high school in 2017–18 during the Minnesota State Fair. Parents reported via iPad their knowledge of and concern about meningococcal disease and their awareness of and willingness to vaccinate with MenB and MenACWY vaccines. We assessed the relationship between meningococcal disease knowledge and concern, MenB and MenACWY vaccine awareness, and willingness to vaccinate with MenB and MenACWY using adjusted logistic regression. Results: Among 445 parents, the majority had not heard of the newly introduced MenB vaccines Bexsero ® (80.0%; 95% CI: 76.0–83.6) or Trumenba ® (82.0%; 95% CI: 78.1–85.5) or the MenACWY vaccines Menactra ® or Menveo ® (68.8%; 95% CI: 64.2–73.0). The majority were at least somewhat willing to vaccinate their teen with MenB vaccine (89.6%; 95% CI: 86.5, 92.3) and MenACWY vaccine (91.2%; 95% CI: 88.2, 93.7). Awareness of MenB vaccines (OR: 3.8; 95% CI: 1.2–12.2) and concern about meningococcal disease (OR: 3.1; 95% CI: 1.5–6.3) were significantly associated with willingness to vaccinate with MenB vaccine. Conclusions: Awareness of MenB vaccine is lacking among parents of teens but is an important predictor of willingness to vaccinate with the newly licensed MenB vaccines.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Parental awareness of Meningococcal B vaccines and willingness to vaccinate their teens

Basta

Becker

et al. 2019

Vaccine

View full text Add to dashboard Cite

show abstract

“…MenB vaccines were used in response to all 10 outbreaks (Table 2). Two of the outbreaks (New Jersey and California) occurred in 2013, before licensure of MenB vaccines; therefore, MenB-4C vaccine was provided through a CDC-sponsored expanded-access investigational new drug protocol ( 15 , 17 ). The remaining 8 outbreaks occurred following the licensure of MenB-4C and MenB-FHbp vaccines in the United States: 3 of the affected universities implemented MenB vaccination using primarily MenB-FHbp, and 5 universities primarily used MenB-4C.…”

Section: Menb Vaccination Responsementioning

confidence: 99%

“…In the 2 outbreaks in 2013, MenB vaccine was provided through an expanded access investigational new drug protocol ( 15 , 17 ). In the 2013 California outbreak, a vaccination campaign was initiated after 4 cases had occurred; no additional cases occurred following MenB vaccination implementation (Figure 1).…”

Section: Menb Vaccination Responsementioning

confidence: 99%

University-Based Outbreaks of Meningococcal Disease Caused by Serogroup B, United States, 2013–2018

Soeters¹,

McNamara²,

Blain³

et al. 2019

Emerg. Infect. Dis.

View full text Add to dashboard Cite

We reviewed university-based outbreaks of meningococcal disease caused by serogroup B and vaccination responses in the United States in the years following serogroup B meningococcal (MenB) vaccine availability. Ten university-based outbreaks occurred in 7 states during 2013–2018, causing a total of 39 cases and 2 deaths. Outbreaks occurred at universities with 3,600–35,000 undergraduates. Outbreak case counts ranged from 2 to 9 cases; outbreak duration ranged from 0 to 376 days. All 10 universities implemented MenB vaccination: 3 primarily used MenB-FHbp and 7 used MenB-4C. Estimated first-dose vaccination coverage ranged from 14% to 98%. In 5 outbreaks, additional cases occurred 6–259 days following MenB vaccination initiation. Although it is difficult to predict outbreak trajectories and evaluate the effects of public health response measures, achieving high MenB vaccination coverage is crucial to help protect at-risk persons during outbreaks of meningococcal disease caused by this serogroup.

show abstract

Using humor to increase COVID‐19 vaccination intention for the unvaccinated: The moderating role of trust in government

Yoon

Lee

Han

et al. 2023

J of Consumer Behaviour

View full text Add to dashboard Cite

Since COVID‐19 was declared a global pandemic, scholars and practitioners have put much effort into testing effective advertising strategies for COVID‐19 vaccinations. Guided by humor theories, this study aimed to examine (1) the effect of humor on persuading COVID‐19 vaccination and (2) the moderating role of trust in government for the unvaccinated population. Across two studies (college students and general adult populations), for lower trust in government individuals, through greater public service advertisement (PSA) processing depth and believability, there was a higher vaccination intention after the humor (non‐humor) advertisement. For higher trust in government individuals, there was evidence that the vaccination intention was lowered after the humor (vs. non‐humor) message through lowered PSA processing depth and believability. This study expands humor theory into testing COVID‐19 vaccination messages while considering an individual psychological factor, trust in the government, that has emerged as an essential determinant to COVID‐19 messaging. The contributions to COVID‐19 vaccination advertising strategy and advertising to the unvaccinated population, in general, are discussed.

show abstract

Understanding Factors Affecting University A Students' Decision to Receive an Unlicensed Serogroup B Meningococcal Vaccine

Cited by 14 publications

References 18 publications

Parental awareness of Meningococcal B vaccines and willingness to vaccinate their teens

Parental awareness of Meningococcal B vaccines and willingness to vaccinate their teens

University-Based Outbreaks of Meningococcal Disease Caused by Serogroup B, United States, 2013–2018

Using humor to increase COVID‐19 vaccination intention for the unvaccinated: The moderating role of trust in government

Contact Info

Product

Resources

About